Candriam SCA’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-454,945
| Closed | -$5.94M | – | 731 |
|
|
2024
Q1 | $5.94M | Buy |
454,945
+104,945
| +30% | +$1.37M | 0.04% | 315 |
|
|
2023
Q4 | $4.46M | Sell |
350,000
-77,972
| -18% | -$994K | 0.03% | 346 |
|
|
2023
Q3 | $5.61M | Buy |
427,972
+357,972
| +511% | +$4.69M | 0.04% | 297 |
|
|
2023
Q2 | $1.79M | Buy |
+70,000
| New | +$1.79M | 0.01% | 517 |
|
|
2023
Q1 | – | Sell |
-105,000
| Closed | -$2.41M | – | 925 |
|
|
2022
Q4 | $2.41M | Hold |
105,000
| – | – | 0.02% | 543 |
|
|
2022
Q3 | $2.32M | Hold |
105,000
| – | – | 0.02% | 560 |
|
|
2022
Q2 | $1.51M | Buy |
105,000
+20,000
| +24% | +$287K | 0.01% | 560 |
|
|
2022
Q1 | $1.61M | Buy |
85,000
+53,000
| +166% | +$1M | 0.01% | 585 |
|
|
2021
Q4 | $596K | Hold |
32,000
| – | – | ﹤0.01% | 735 |
|
|
2021
Q3 | $861K | Buy |
32,000
+12,000
| +60% | +$323K | 0.01% | 726 |
|
|
2021
Q2 | $625K | Buy |
+20,000
| New | +$625K | ﹤0.01% | 781 |
|